Differential regulation of Streptococcus pneumoniae-induced human MUC5AC mucin expression through distinct MAPK pathways

American Journal of Translational Research

Volumn 1, Issue 3, 2009, Pages 300-311

  Lim, Jae Hyang ^a   Kim, Hyun Jung ^a   Komatsu, Kensei ^a   Ha, Unhwan ^b   Huang, Yuxian ^c   Jono, Hirofumi ^a   Kweon, Soo Mi ^d   Lee, Jiyun ^a   Xu, Xiangbin ^a   Zhang, Gen Sheng ^e   Shen, Huahao ^e   Kai, Hirofumi ^f   Zhang, Wenhong ^c   Xu, Haidong ^a   Li, Jian Dong ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Korea University   (South Korea)

^c FUDAN UNIVERSITY   (China)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^f KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AP 1; COPD; ERK; JNK; MUC5AC mucin; Otitis media; Streptococcus pneumonia

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; MUCIN 5AC; RAF PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LOWER RESPIRATORY TRACT INFECTION; MALE; MOLECULAR DYNAMICS; MOUSE; MUCUS SECRETION; MUTATIONAL ANALYSIS; NONHUMAN; OTITIS MEDIA; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 77953448759     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Kopp E and R Medzhitov. Recognition of microbial infection by Toll-like receptors. Curr Opin Immunol, 2003; 15: 396-401
2. Rose MC and JA Voynow. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev, 2006; 86: 245-278
3. Knowles MR and RC Boucher. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest, 2002; 109: 571-577
4. Rose MC, TJ Nickola and JA Voynow. Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am J Respir Cell Mol Biol, 2001; 25: 533-537
5. Majima Y, Y Hamaguchi, K Hirata, K Takeuchi, A Morishita and Y Sakakura. Hearing impairment in relation to viscoelasticity of middle ear effusions in children. Ann Otol Rhinol Laryngol, 1988; 97: 272-274
6. Reichman J and WC Healey. Learning disabilities and conductive hearing loss involving otitis media. J Learn Disabil, 1983; 16: 272-278
7. Foxwell AR, JM Kyd and AW Cripps. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev, 1998; 62: 294-308
8. Lim DJ, YM Chun, HY Lee, SK Moon, KH Chang, JD Li and A Andalibi. Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine, 2000; 19 Suppl 1: S17-25
9. Chen YP, HH Tong, James and TF Demaria. Detection of mucin gene expression in normal rat middle ear mucosa by reverse transcriptase-polymerase chain reaction. Acta Otolaryngol, 2001; 121: 45-51
10. Rose AS, J Prazma, SH Randell, HC Baggett, AP Lane and HC Pillsbury. Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion. Otolaryngol Head Neck Surg, 1997; 116: 308-316
11. Gates GA. Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg, 1996; 114: 525-530
12. Klein JO. The burden of otitis media. Vaccine, 2000; 19 Suppl 1: S2-8
13. Teele DW, JO Klein and B Rosner. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis, 1989; 160: 83-94
14. Murphy TF. Bacterial otitis media: pathogenetic considerations. Pediatr Infect Dis J, 2000; 19: S9-15; discussion S15-16
15. Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr, 2001; 160: 407-413
16. DeMaria TF, LO Bakaletz, T Chonmaitree, T Heikkinen, DS Hurst, H Kawauchi, Y Kurono, JA Patel, TM Sih, LE Stenfors and M Suzuki. Recent advances in otitis media. 6. Microbiology and immunology. Ann Otol Rhinol Laryngol Suppl, 2002; 188: 62-81
17. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J, 1997; 16: 449-456
18. Straetemans M, EA Sanders, RH Veenhoven, AG Schilder, RA Damoiseaux and GA Zielhuis. Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media. Pediatr Infect Dis J, 2003; 22: 515-524
19. Veenhoven R, D Bogaert, C Uiterwaal, C Brouwer, H Kiezebrink, J Bruin, IJ E, P Hermans, R de Groot, B Zegers, W Kuis, G Rijkers, A Schilder and E Sanders. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet, 2003; 361: 2189-2195
20. Ha U, JH Lim, H Jono, T Koga, A Srivastava, R Malley, G Pages, J Pouyssegur and JD Li. A novel role for IkappaB kinase (IKK) alpha and IKKbeta in ERK-dependent up-regulation of MUC5AC mucin transcription by Streptococcus pneumoniae. J Immunol, 2007; 178: 1736-1747
21. Ha UH, JH Lim, HJ Kim, W Wu, S Jin, H Xu and JD Li. MKP1 regulates the induction of MUC5AC mucin by Streptococcus pneumoniae pneumolysin by inhibiting the PAK4-JNK signaling pathway. J Biol Chem, 2008; 283: 30624-30631
22. Lim JH, B Stirling, J Derry, T Koga, H Jono, CH Woo, H Xu, P Bourne, UH Ha, H Ishinaga, A Andalibi, XH Feng, H Zhu, Y Huang, W Zhang, X Weng, C Yan, Z Yin, DE Briles, RJ Davis, RA Flavell and JD Li. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. Immunity, 2007; 27: 349-360
23. Lim JH, U Ha, A Sakai, CH Woo, SM Kweon, H Xu and JD Li. Streptococcus pneumoniae synergizes with nontypeable Haemophilus influenzae to induce inflammation via upregulating TLR2. BMC Immunol, 2008; 9: 40
24. Benton KA, MP Everson and DE Briles. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect Immun, 1995; 63: 448-455
25. Benton KA, JC Paton and DE Briles. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model. Microb Pathog, 1997; 23: 201-209
26. Chun YM, SK Moon, HY Lee, P Webster, DE Brackmann, JS Rhim and DJ Lim. Immortalization of normal adult human middle ear epithelial cells using a retrovirus containing the E6/E7 genes of human papillomavirus type 16. Ann Otol Rhinol Laryngol, 2002; 111: 507-517
27. Kweon SM, B Wang, D Rixter, JH Lim, T Koga, H Ishinaga, LF Chen, H Jono, H Xu and JD Li. Synergistic activation of NF-kappaB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKbeta-IkappaBalpha, and p38 MAPK. Biochem Biophys Res Commun, 2006; 351: 368-375
28. Jono H, JH Lim, LF Chen, H Xu, E Trompouki, ZK Pan, G Mosialos and JD Li. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J Biol Chem, 2004; 279: 36171-36174
29. Komatsu K, H Jono, JH Lim, A Imasato, H Xu, H Kai, C Yan and JD Li. Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced MUC5AC mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. Biochem Biophys Res Commun, 2008; 377: 763-768
30. Ishinaga H, H Jono, JH Lim, K Komatsu, X Xu, J Lee, CH Woo, H Xu, XH Feng, LF Chen, C Yan and JD Li. Synergistic induction of nuclear factor-kappaB by transforming growth factor-beta and tumour necrosis factor-alpha is mediated by protein kinase A-dependent RelA acetylation. Biochem J, 2009; 417: 583-591
31. Lim JH, UH Ha, CH Woo, H Xu and JD Li. CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumonia. Cell Microbiol, 2008; 10: 2247-2256
32. Ishinaga H, H Jono, JH Lim, SM Kweon, H Xu, UH Ha, T Koga, C Yan, XH Feng, LF Chen and JD Li. TGF-beta induces p65 acetylation to enhance bacteria-induced NF-kappaB activation. Embo J, 2007; 26: 1150-1162
33. Mikami F, JH Lim, H Ishinaga, UH Ha, H Gu, T Koga, H Jono, H Kai and JD Li. The transforming growth factor-beta-Smad3/4 signaling pathway acts as a positive regulator for TLR2 induction by bacteria via a dual mechanism involving functional cooperation with NF-kappaB and MAPK phosphatase 1-dependent negative cross-talk with p38 MAPK. J Biol Chem, 2006; 281: 22397-22408
34. Shuto T, H Xu, B Wang, J Han, H Kai, XX Gu, TF Murphy, DJ Lim and JD Li. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc Natl Acad Sci U S A, 2001; 98: 8774-8779
35. Wang B, DJ Lim, J Han, YS Kim, CB Basbaum and JD Li. Novel cytoplasmic proteins of nonty-peable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J Biol Chem, 2002; 277: 949-957
36. Jono H, H Xu, H Kai, DJ Lim, YS Kim, XH Feng and JD Li. Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem, 2003; 278: 27811-27819
37. Chen R, JH Lim, H Jono, XX Gu, YS Kim, CB Basbaum, TF Murphy and JD Li. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem Biophys Res Commun, 2004; 324: 1087-1094
38. Jono H, T Shuto, H Xu, H Kai, DJ Lim, JR Gum, Jr., YS Kim, S Yamaoka, XH Feng and JD Li. Transforming growth factor-beta-Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription. J Biol Chem, 2002; 277: 45547-45557
39. Shuto T, A Imasato, H Jono, A Sakai, H Xu, T Watanabe, DD Rixter, H Kai, A Andalibi, F Linthicum, YL Guan, J Han, AC Cato, DJ Lim, S Akira and JD Li. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem, 2002; 277: 17263-17270
40. Huang Q, J Yang, Y Lin, C Walker, J Cheng, ZG Liu and B Su. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol, 2004; 5: 98-103
41. Lim JH, H Jono, T Koga, CH Woo, H Ishinaga, P Bourne, H Xu, UH Ha and JD Li. Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice. PLoS ONE, 2007; 2: e1032
42. Raman M and MH Cobb. MAP kinase modules: many roads home. Curr Biol, 2003; 13: R886-888
43. Li JD, W Feng, M Gallup, JH Kim, J Gum, Y Kim and C Basbaum. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc Natl Acad Sci U S A, 1998; 95: 5718-5723
44. Weston CR and RJ Davis. The JNK signal transduction pathway. Curr Opin Genet Dev, 2002; 12: 14-21
45. Carrie S, DA Hutton, JP Birchall, GG Green and JP Pearson. Otitis media with effusion: components which contribute to the viscous properties. Acta Otolaryngol, 1992; 112: 504-511
46. Basbaum C, H Lemjabbar, M Longphre, D Li, E Gensch and N McNamara. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med, 1999; 160: S44-48
47. Kerschner JE. Mucin gene expression in human middle ear epithelium. Laryngoscope, 2007; 117: 1666-1676